Smoking Cessation Aids Market Size (2024 - 2029)

Smoking Cessation Aids Market Analysis

The Smoking Cessation Aids Market size is estimated at USD 32.60 billion in 2024, and is expected to reach USD 55.84 billion by 2029, growing at a CAGR of 11.37% during the forecast period (2024-2029).

Factors such as a large population addicted to smoking, growing awareness of the hazards of smoking, and banning advertisements of tobacco products are expected to boost market growth over the forecast period.

Increasing government initiatives toward organizing various tobacco and smoking cessation campaigns raise awareness among the population regarding their harmful effects on the body. It is anticipated to fuel the adoption of smoking cessation devices and products among users. For instance, in May 2022, K Sudhakar, the Health Minister of Karnataka, India, launched the 'IndiaVsTobacco' campaign. This initiative featured QR code-enabled billboards and posters aimed at mobilizing youth, parents, and institutions to combat tobacco usage. The interactive billboards were designed to initiate conversations about the dangers of secondhand smoke and the broader health risks associated with tobacco. Campaigns like these not only raise awareness about smoking hazards and treatments but also catalyze market growth.

The escalating use of tobacco, particularly in the form of cigarettes, has contributed to a growing global healthcare burden. Data from the Centers for Disease Control and Prevention (CDC) in November 2023 revealed that 6.6% of middle school students and 12.6% of high school students used tobacco products. Therefore, with the high number of smokers, the usage of nicotine replacement therapy and smoking cessation products is expected to increase, which is expected to boost market growth over the forecast period.

Furthermore, the rising focus by companies on developing and launching smoking cessation drugs and devices in the market is expected to increase their adoption among users, which is anticipated to augment market growth over the forecast period. For instance, in February 2022, betapharm Arzneimittel GmbH launched the first generic nicotine chewing gum, Nicotine Beta, in the German market. It is a generic product underlining the advantages of NRT (nicotine replacement therapy).

Moreover, the rising number of clinical studies conducted by key players to develop novel drugs for smoking cessation is anticipated to augment market growth over the forecast period. For instance, in May 2024, Achieve Life Sciences Inc. released the findings of its ORCA-V1 trial in the Journal of the American Medical Association (JAMA), Internal Medicine. The study, conducted on 160 non-smoking adults who were e-cigarette or nicotine vape users attempting to quit, evaluated the effectiveness and safety of a 3 mg dose of cytisinicline given three times a day for 12 weeks, as opposed to a placebo.

The market studied is expected to grow over the forecast period due to factors such as growing awareness campaigns, increasing use of cigarettes, and product launches by market players. However, the adverse effects of drugs are likely to impede the market's growth over the forecast period.

Smoking Cessation Aids Industry Segmentation

As per the scope of the report, tobacco use can lead to tobacco/nicotine dependence and serious health problems. Quitting smoking reduces greatly the risk of developing smoking-related diseases. Tobacco/nicotine dependence is a condition that often requires repeated treatment, but there are helpful treatments and resources for quitting. Tobacco smoke contains a deadly mix of more than 7,000 chemicals, of which hundreds are harmful, and about 70 can cause cancer.

The smoking cessation aids market is segmented by product, end user, and geography. By product, the market is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and other products. By end user, the market is segmented into hospital pharmacies, online channels, retail pharmacies, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the market sizes and forecasts in value (USD) for the above segments.